Elon Musk's brain-chip startup Neuralink said on Tuesday its experimental implant aimed at restoring vision received the U.S. Food and Drug Administration's "breakthrough device" designation. The FDA's breakthrough tag is given to certain medical devices that provide treatment or diagnosis of life-threatening conditions.

Elon Musk's brain-chip startup has just received its first big win, the breakthrough device, experimental implant, Blindsight got approval from the US Food and

Elon Musk's Neuralink has received FDA approval for its vision-restoring implant, Blindsight. This breakthrough device aims to help people who have lost their vision or were born blind. It works by directly stimulating the visual cortex,

Elon Musk's brain-chip startup Neuralink announces its experimental implant can restore vision, receives US FDA 'breakthrough device' designation.

Elon Musk's brain-chip company Neuralink has received the FDA’s "breakthrough device" designation for its experimental vision-restoring implant, Blindsight.

With Blindsight now receiving the FDA’s Breakthrough Device Designation, Neuralink looks set to push forward with technology to help those with vision disabilities as well. Stay tuned as we continue to follow this story for further updates.

Elon Musk's Neuralink has received the FDA's breakthrough device designation for its experimental brain-chip implant, Blindsight, aimed at restoring vision. The device could help even those who have lost both eyes and their optic nerve.

Elon Musk-owned neurotechnology firm Neuralink has received the U.S. FDA’s breakthrough device designation for its brain implant, Blindsight. Read more here.